Starting on day 2 after the initiation of treatment, a clear difference in tumor growth rate became apparent, with tumors in the Fn14•TRAIL treatment group growing slower or even decreasing in size (Figure 6A,B). This evidence concerns the gene TNFSF10 and neoplasm.